At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Jul 2, 2026 at 16:08 ET
Two EVP-level insiders at Royalty Pharma (RPRX) sold a combined $7.85M in shares over a 7-day window, but this represents only ~0.024% of the company's $32.1B market cap. The selling is trivial in size relative to the company's valuation and is unlikely to carry a material signal.
- EVP & Chairman, Partnering Christopher Hite sold $7.35M across four open-market trades at $56.44–$57.10.
- EVP, Research & Investments Marshall Urist sold $508K at $55.88.
- Director Bonnie Bassler received a non-cash grant of 689 shares worth $37.5K.
- Total insider cash sales of $7.85M are just 0.024% of RPRX's $32.1B market cap.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access